Star Imaging and Path Lab IPO: Check GMP, price band, issue size and other details – News Air Insight

Spread the love


Star Imaging and Path Lab, a Delhi-based diagnostic healthcare services provider, is set to open its IPO on August 8, aiming to raise Rs 69.47 crore through a book-built SME issue. The offering includes a fresh issue of 39.2 lakh shares worth Rs 55.66 crore and an offer for sale (OFS) of 9.72 lakh shares aggregating to Rs 13.80 crore.

The issue will close on August 12, with listing expected on the BSE SME platform on August 18.


The price band for the IPO is set at Rs 135–142 per share, with a minimum application size of 2,000 shares. There is no active grey market premium (GMP) as of now, indicating a cautious sentiment ahead of the listing despite strong financial performance.

Share India Capital Services is acting as the lead manager, and Kfin Technologies is the registrar.

Star Imaging operates across a wide network, offering a comprehensive suite of radiology and pathology services, including digital X-rays, mammography, 4D/5D ultrasounds, CT scans, MRI, histopathology, microbiology, and PCR-based diagnostics.


As of September 2024, the company had a team of 209 full-time employees, comprising technical staff, medical professionals, and management personnel.The company has demonstrated steady financial growth. For the year ended March 2025, Star Imaging reported revenues of Rs 83.79 crore, up 5% YoY, and PAT of Rs 15.96 crore, a 28% increase from the previous year.The company intends to use the IPO proceeds to meet working capital needs (Rs 25 crore), repay debts (Rs 12 crore), and fund the purchase of refurbished medical equipment (Rs 5.14 crore). A portion will also be deployed for general corporate purposes.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *